铝碳酸镁及血凝酶联合奥美拉唑治疗胃出血的临床疗效  

Clinical efficacy of magnesium aluminate and hemocoagulase combined with omeprazole for gastric hemorrhage

作　　者：谢龙芳 XIE Long-fang(Jinggangshan Second People's Hospital,Jinggangshan 343600,China)

机构地区：[1]江西省井冈山市第二人民医院

出　　处：《临床合理用药杂志》2019年第30期13-14,共2页Chinese Journal of Clinical Rational Drug Use

摘　　要：目的探讨铝碳酸镁及血凝酶联合奥美拉唑治疗胃出血的临床疗效。方法选取井冈山市第二人民医院2017年9月-2018年9月收治的胃出血患者44例,随机分为参照组和试验组,各22例。参照组给予铝碳酸镁联合奥美拉唑治疗,试验组在参照组基础上给予血凝酶治疗,两组患者均持续治疗5 d。比较两组患者临床疗效,生活质量及住院时间,并观察两组患者不良反应发生情况。结果试验组总有效率、生活质量评分高于参照组,住院时间短于参照组,不良反应发生率低于参照组(P<0.05)。结论铝碳酸镁及血凝酶与奥美拉唑联合治疗胃出血的临床疗效确切,可提高患者生活质量,缩短住院时间,且安全性高。Objective To investigate the clinical efficacy of magnesium aluminate and hemocoagulase combined with omeprazole for gastric hemorrhage.Methods A total of 100 cases of patients with gastric hemorrhage were selected from September 2017 to September 2018 in Jinggangshan Second People’s Hospital,which were randomly divided into the reference group and the experimental group,22 cases in each group.The reference group was treated with magnesium aluminium carbonate combined with omeprazole.The experimental group was treated with hemagglutinin baesd on the control group.Both groups were treated for 5 days.The clinical efficacy,quality of life and hospitalization time of the two groups were compared,and the adverse reactions of the two groups were observed.Results The the experimental group of total effective rate and quality of life score were higher than the reference group,the length of hospitalization was shorter than the reference group,and the incidence rate of adverse reactions was lower than the reference group(P<0.05).Conclusion Magnesium aluminium carbonate and hemocoagulase combined with omeprazole are effective in the treatment of gastric hemorrhage,which can improve the quality of life of patients,shorten hospital stay,and with high safety.

关 键 词：胃肠出血 铝碳酸镁 血凝酶 奥美拉唑 治疗结果 

分 类 号：R47[医药卫生—护理学]